Back to News
Market Impact: 0.3
Dr. Reddy's Laboratories Limited Reports Revenues of Rs. 86,708 Million for the Quarter Ended September 30, 2026
Source: Nasdaq
Corporate EarningsHealthcare & BiotechCompany Fundamentals
Dr. Reddy's Laboratories reported revenue of Rs. 86,708 million for the three months ended September 30, 2026, down 2% from Rs. 88,051 million in the year-earlier period. Profit for the period also declined from the prior-year figure, but the article excerpt does not provide the amount.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
RDY-0.35
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- Apple’s $2,000 iPhone Duo Debuts With Limited Supply
- Boeing 777 freighter output halted for two months over supplier row
- Exclusive-Boeing supplier dispute has halted 777 freighter production for two months, sources say
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- AllMind's Data Standardization Methodology: Our Approach to Fundamentals
- What Makes Financial Data Ready for AI Research?